Researchers at the University of Florida developed ΨDNA, a DNA-guided CRISPR–Cas12 system designed to target cellular RNA using DNA guide scaffolds rather than RNA guides. The approach aims to improve stability and reduce RNA-guide-specific limitations, while enabling programmable RNA control for diagnostics and potential therapeutic transcriptome modulation, including reported detection and knockdown performance in experimental settings.